Actively Recruiting
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Led by Dana-Farber Cancer Institute · Updated on 2026-01-22
62
Participants Needed
1
Research Sites
229 weeks
Total Duration
On this page
Sponsors
D
Dana-Farber Cancer Institute
Lead Sponsor
P
Pfizer
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research is to determine whether a 16-week culturally tailored, technology-based, aerobic and resistance exercise intervention improves cardiovascular risk factors in Black men diagnosed with prostate cancer and are undergoing androgen deprivation therapy (ADT), and whether it will also improve physical fitness and function, body composition, and outcomes such as quality of life, cancer symptoms, and self-esteem. Participants in this study will be randomly assigned to one of two groups: 1) Aerobic and resistance exercise, or 2) Usual care.
CONDITIONS
Official Title
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be 18 years or older
- Histologically diagnosed with localized or metastatic prostate cancer
- Currently receiving androgen deprivation therapy for at least one month and plan to continue for at least 4 months
- Self-identify as Black
- Medically cleared to exercise by a physician or certified clinical exercise physiologist
- No medical conditions that could worsen with exercise, such as bone disease at risk of fracture or uncontrolled cardiopulmonary or metabolic diseases
- Speak English and/or Spanish
- Currently participate in 60 minutes or less of moderate or vigorous structured exercise per week
- Willing and able to travel to Dana-Farber Cancer Institute for data collection
- Able to communicate and complete forms in English and/or Spanish
You will not qualify if you...
- Not receiving androgen deprivation therapy
- Have uncontrolled cardiopulmonary or metabolic diseases that could worsen with exercise
- Do not speak English or Spanish
- Have a secondary diagnosis besides basal cell carcinoma
- Participate in more than 60 minutes of moderate or vigorous structured exercise per week
- Unable to travel to Dana-Farber Cancer Institute for study visits
- Unable to comply with safety monitoring requirements as judged by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Dana Farber Cancer Institute
Boston, Massachusetts, United States, 02215
Actively Recruiting
Research Team
C
Christina Dieli-Conwright, PhD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here